| Application no. and date | 14855343.1 (espacenet) (Federated) (European Patent Register), 20141023 | | Patent/reg. no. and date | DK/EP 3060229, 20210825 | | Publication date | 20160831 | | Priority no. and date | US 201361895143 P, 20131024 | | EP pub. no. and date |
EP 3060229 20160831 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | 1592106 | | Inventor | MCGIVNEY, James, c/o MedImmune LLC
One Medimmune Way
Gaithersburg, MD 20878, US,
LEACH, William, c/o Medimmune LLC
One Medimmune Way
Gaithersburg, MD 20878, US,
LEWUS, Rachael, c/o Medimmune LLC
One Medimmune Way
Gaithersburg, MD 20878, US,
NEWELL, Kelcy, c/o Medimmune LLC
One Medimmune Way
Gaithersburg, MD 20878, US,
STEWART, Kevin Douglas, c/o Medimmune LLC
One Medimmune Way
Gaithersburg, MD 20878, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/18 (2017.01) , A61K 9/00 (2006.01) , C07K 16/28 (2006.01) | | Title | STABILE, VANDIGE ANTISTOFFORMULERINGER | | Int. application no. | US2014061997 | | Int. publication no. | WO2015061584 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
